Status:

RECRUITING

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

Lead Sponsor:

Cedars-Sinai Medical Center

Collaborating Sponsors:

National Cancer Institute (NCI)

University of California, Los Angeles

Conditions:

Cancer Pain

Visceral Pain

Eligibility:

All Genders

18-99 years

Phase:

NA

Brief Summary

Patients with digestive tract malignancy often experience severe and unremitting abdominal pain that negatively affects physical, emotional, and social function, as well as health related quality of l...

Detailed Description

GI cancer pain is a prevalent and costly condition. Medical therapy is not always effective for managing GI cancer pain; there is a need for drug-free alternative to complement or even replace medical...

Eligibility Criteria

Inclusion

  • Have a primary malignancy of the biliary tract, colon, liver, pancreas, peritoneum, rectum, small intestine, or stomach, with no plan for resection during the study period
  • Tumor types including, but not limited to, adenocarcinoma, squamous cell carcinoma, neuroendocrine tumors, and tumors of mesenchymal origin will be eligible
  • Have clinically significant visceral pain, measured using the standardized NIH PROMIS GI Pain Scale defined as scoring at least 5 points above the nationally normed score
  • Ability to read and write in English

Exclusion

  • Have a condition that interferes with VR usage, including but not limited to seizures, facial injury precluding safe placement of headset, and visual impairments
  • Have cognitive impairment that affects protocol participation. This will be done with a three part cognitive assessment during the initial phone call to assess eligibility followed by consent discussion if eligible.
  • Have brain metastases
  • Have a prognosis of \<3 months from the time of enrollment per treating oncologist

Key Trial Info

Start Date :

October 5 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 16 2026

Estimated Enrollment :

360 Patients enrolled

Trial Details

Trial ID

NCT04907643

Start Date

October 5 2021

End Date

June 16 2026

Last Update

October 30 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Cedars-Sinai Medical Center

Los Angeles, California, United States, 90048